Correlation Engine 2.0
Clear Search sequence regions


  • avian (1)
  • bacteria (2)
  • chickens (1)
  • coli (4)
  • esters (1)
  • humans (3)
  • methyl (1)
  • public health (1)
  • research (1)
  • vaccines (1)
  • vaccines escherichia coli (3)
  • Sizes of these terms reflect their relevance to your search.

    The application of next-generation molecular, biochemical and immunological methods for developing new vaccines, antimicrobial compounds, probiotics and prebiotics for zoonotic infection control has been fundamental to the understanding and preservation of the symbiotic relationship between animals and humans. With increasing rates of antibiotic use, resistant bacterial infections have become more difficult to diagnose, treat, and eradicate, thereby elevating the importance of surveillance and prevention programs. Effective surveillance relies on the availability of rapid, cost-effective methods to monitor pathogenic bacterial isolates. In this opinion article, we summarize the results of some research program initiatives for the improvement of live vaccines against avian enterotoxigenic Escherichia coli using virulence factor gene deletion and engineered vaccine vectors based on probiotics. We also describe methods for the detection of pathogenic bacterial strains in eco-environmental headspace and aerosols, as well as samples of animal and human breath, based on the composition of volatile organic compounds and fatty acid methyl esters. We explain how the introduction of these low-cost biotechnologies and protocols will provide the opportunity to enhance co-operation between networks of resistance surveillance programs and integrated routine workflows of veterinary and clinical public health microbiology laboratories.

    Citation

    José E Belizário, Marcelo P Sircili. Novel biotechnological approaches for monitoring and immunization against resistant to antibiotics Escherichia coli and other pathogenic bacteria. BMC veterinary research. 2020 Nov 02;16(1):420

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33138825

    View Full Text